Pfizer CFO says drugmaker will 'supplement' Metsera deal as part of broader obesity ambitions

Now that Pfizer has acquired Metsera, the New York drug giant is likely to be peppered with questions about its obesity R&D strategy going forward. That was evident during Pfizer CFO Dave ...